131 related articles for article (PubMed ID: 23240787)
1. Iron complex, dabigatran and toxic epidermal necrolysis syndrome: a case-report.
Tsoumpris A; Tzimas T; Gkabrelas K; Akritidis N
J Clin Pharm Ther; 2013 Apr; 38(2):177-8. PubMed ID: 23240787
[TBL] [Abstract][Full Text] [Related]
2. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
Bastuji-Garin S; Rzany B; Stern RS; Shear NH; Naldi L; Roujeau JC
Arch Dermatol; 1993 Jan; 129(1):92-6. PubMed ID: 8420497
[TBL] [Abstract][Full Text] [Related]
3. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
4. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
5. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
Wychowski MK; Kouides PA
Ann Pharmacother; 2012 Apr; 46(4):e10. PubMed ID: 22496474
[TBL] [Abstract][Full Text] [Related]
6. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
de Rego JA; Goldstein DM
Hillside J Clin Psychiatry; 1985; 7(2):141-8. PubMed ID: 4077031
[TBL] [Abstract][Full Text] [Related]
7. [Iron protein-succinylate in the treatment of adult iron-deficiency anemia].
Pujol Farriols R; Anglada Oriol M; Formiga Pérez F; Fernández-Sabe N; Mitjavila Vileró F; Vidaller Palacín A
An Med Interna; 2002 Dec; 19(12):651-2. PubMed ID: 12593038
[No Abstract] [Full Text] [Related]
8. [Legofer--a new approach in the treatment of iron deficiency. Pharmacological and biopharmacological characteristics of legofer (ferric protein succinylate)].
Akush Ginekol (Sofiia); 2002; 41 Suppl 1():21-3. PubMed ID: 12412350
[No Abstract] [Full Text] [Related]
9. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
Boruah PK; Bolesta S; Shetty SM
Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
[TBL] [Abstract][Full Text] [Related]
10. Toxic epidermal necrolysis due to voriconazole: case report and review.
Gomulka J; Wilson BD; Joyce JC
Dermatol Online J; 2014 Sep; 20(9):. PubMed ID: 25244163
[TBL] [Abstract][Full Text] [Related]
11. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
[TBL] [Abstract][Full Text] [Related]
12. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature.
Kakar R; Paugh H; Jaworsky C
Dermatology; 2013; 227(3):209-13. PubMed ID: 24135381
[TBL] [Abstract][Full Text] [Related]
13. Toxic epidermal necrolysis.
Lacy JA
Nutr Clin Pract; 1991 Feb; 6(1):18-20. PubMed ID: 1775102
[TBL] [Abstract][Full Text] [Related]
14. Extensive postoperative ecchymosis in a patient taking dabigatran.
Wagner CA; Oberoi N; Ahluwalia PK
J Minim Invasive Gynecol; 2013; 20(1):127-30. PubMed ID: 23312256
[TBL] [Abstract][Full Text] [Related]
15. Dermatologic emergencies.
Usatine RP; Sandy N
Am Fam Physician; 2010 Oct; 82(7):773-80. PubMed ID: 20879700
[TBL] [Abstract][Full Text] [Related]
16. Iron protein succinylate: preclinical safety assessment.
Forster R
Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):53-60. PubMed ID: 8458676
[TBL] [Abstract][Full Text] [Related]
17. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
Baruch L; Sherman O
Ann Pharmacother; 2011 Jul; 45(7-8):e40. PubMed ID: 21712509
[TBL] [Abstract][Full Text] [Related]
18. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
Aberer W; Stingl G; Wolff K
Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of oral iron protein succinylate: a systematic review of three decades of research.
Martínez Francés A; Leal Martínez-Bujanda J
Curr Med Res Opin; 2020 Apr; 36(4):613-623. PubMed ID: 31944128
[No Abstract] [Full Text] [Related]
20. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
